JULIE SIM: Open Payments
NPI 1306483011 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,238 in 41 payments from 17 companies in 2025. Trend: 2023 $267 · 2024 $181 · 2025 $1,238
Food & beverage: $1,238
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $469 |
| Madrigal Pharmaceuticals | 4 | $221 |
| ABBVIE INC. | 11 | $152 |
| Lucid Diagnostics Inc. | 1 | $75 |
| Aimmune Therapeutics, Inc. | 2 | $44 |
| QOL Medical, LLC | 1 | $39 |
| Novo Nordisk Inc | 1 | $33 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
Products named: TREMFYA, REZDIFFRA, RINVOQ, ZENPEP, Sucraid, MAVYRET, CREON, Wegovy.
Industry payments across SC — which companies pay providers there.
